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We aimed at analyzing important predictive factors for experienced negative emotional and social effects of
rheumatoid arthritis (RA) two years after diagnosis in patients aged 18–65 years. The first group included 41
participants, who had psychosocial problems (PSP) already at diagnosis, and who received an intervention by a
medical social worker to improve coping capacity and social situation. The second group included 54 patients
(NPSP) without such problems at diagnosis. All completed a questionnaire mapping their social situation, the
Hospital Anxiety and Depression Scale (HADS), the Sense of Coherence Scale (SOC) and the General Coping
Questionnaire (GCQ) at diagnosis and after 24 months. The most pronounced predictive factor for a strong impact
of the disease was high scores on HADS depression scale. After 24 months, PSP participants had a more strained
life situation, with higher scores on anxiety and depression and lower on SOC, in comparison with NPSP. NPSP
participants improved their coping strategies regarding self-trust, cognitive revaluation, protest and intrusion, but
deteriorated regarding problem focusing and social trust. PSP patients kept their initial coping strategies, except for
intrusion decreasing over time, and seemed to have a more rigid coping pattern. However, the experienced
negative impact of the disease increased over time in both groups despite improvement in sickness related data.
Mostly influenced areas were economy, leisure time activities and social life. We conclude that psychosocial
consequences of RA are more connected to emotional and social vulnerability than are RA-related clinical factors.
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Rheumatoid arthritis (RA) is a common chronic dis-
order, affecting nearly 0.5% of the Swedish population
(Simonsson et al. 1999), with an estimated annual inci-
dence among women at 0.29‰ vs. 0.18‰ among men
(Soderlin et al. 2002). Negative consequences of a chronic
disease such as RA could be of both somatic and psycho-
social origin. Even though medical treatment has improved
over time, knowledge of psychosocial consequences of RA
is limited. RA is associated with socio-economic changes
even at early stages of the disease (Albers et al. 1999), in-
cluding work disability (Sokka 2003), and psychosocial
problems are present almost in half of the patients already
at diagnosis (Gafvels et al. 2012). These problems are often
associated with depression and functional status (Morris
et al. 2008), with difficulties at work appearing even at early* Correspondence: per.wandell@ki.se
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in any medium, provided the original work is pphases (Geuskens et al. 2007). The risk of depression is
higher in early stages of RA (Treharne et al. 2005), and
findings in a review article do suggest that psychological
interventions may be more effective for patients with a
shorter duration of the disease (Astin et al. 2002). Low so-
cial support is considered a predictor of depression and
anxiety in people with RA (Zyrianova et al. 2006), and high
social support might weaken the effects of distress, at least
in people at an early stage of RA (Strating et al. 2006).
Coping is a theoretical concept often used when dis-
cussing a person’s ability to adapt to stressors in general
(Lazarus and Folkman 1984), but it is also commonly
used to describe a person’s adaptation to a chronic dis-
ease (Walker et al. 2004; Persson et al. 1999). One defin-
ition of coping is “constantly changing cognitive and
behavioural efforts to manage specific external and/or in-
ternal demands that are appraised as taxing or exceeding
the resources of a person” (Lazarus and Folkman 1984).
Active coping could be defined as “efforts to act on the
source of stress or one’s emotions” and passive coping asan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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2012). Studies have shown that patients with RA using
passive coping strategies are at risk of developing psycho-
logical co-morbidity (Treharne et al. 2007), and to have
more pain (Covic et al. 2000). However, in general it is un-
clear which coping strategies leads to psychological dis-
tress in later in the course of RA (Vriezekolk et al. 2011).
Another concept related to coping is “Sense of coherence”
(SOC) (Antonovsky 1993), focusing on health-preserving
factors in counteracting negative consequences of psycho-
social stress (Schnyder et al. 1999). The concept of SOC
deals with an individual’s capacity to cope with psycho-
social stress. Protective factors measured by the scale are
comprehensiveness, meaningfulness, manageability, and
resistance resources.
The aim of this study was to investigate predictive fac-
tors for negative effects of RA by studying the psycho-
social situation 24 months after diagnosis in two groups
of RA patients. The hypothesis was that a vulnerable
psychosocial situation would predict a negative effect of
RA at the follow-up.
Materials and methods
Setting and participants
This paper is based on a prospective study on psycho-
social consequences of RA and diabetes mellitus (Gafvels
et al. 2012; Rane et al. 2011). Measurements were per-
formed at inclusion and after 24 months. The RA partici-
pants were patients from the Department of Rheumatology,
Karolinska University Hospital, recruited from the begin-
ning of 2001 to the end of 2004. All patients fulfilling the
inclusion criteria: with a new diagnosis (not older than
three months) of RA, according to the American College
of Rheumatology (ACR) 1987 classification criteria (Levin
et al. 1996); aged 18 to 65 years; and able to communicate
in Swedish; were invited to participate in the study.
Altogether 123 patients (90 women) were eligible and re-
ceived verbal and written information about the study.
However, 19 of these declined to participate before the
study started, and four dropped out during the data col-
lection (two died, one was diagnosed with cancer and the
fourth declined during the first part of the data collection).
These 23 patients (15 women) were excluded from the
study (Gafvels et al. 2012). No significant differences were
found as regards age and sex between the participants and
non-participants. The participants were divided into two
groups based on a semi-structured interview, which con-
sisted of a psychosocial mapping, serving as a basis of psy-
chosocial diagnosis, according to praxis in social work in
health care (Gafvels et al. 2012). The first group (n = 41)
consisted of patients with psychosocial problems (PSP)
who received intervention by the medical social worker
in the study. Five patients with psychosocial problems
did not want to pay visits to the hospital social worker,and were followed up by telephone calls every sixth
month. As they did not receive any intervention they were
excluded from the analysis. The second group (n = 54)
consisted of patients with no pronounced psychosocial
problems (NPSP).
Outcomes
The main outcome variable was the experienced nega-
tive effect of the disease two years after the diagnosis.
Response alternatives were: 1) little or not at all, 2) mod-
erate and 3) great or very great, which we dichotomized
into great or very great negative effect, i.e. response al-
ternative 3, versus not, i.e. response alternatives 1 and 2.
Another question with the same response alternatives
registered expected consequences at baseline (Gafvels
et al. 2012). Information of influenced areas of life was
also collected.
Categorization of psychosocial problems
Psychosocial problems were classified as: a) strongly
negative, or inadequate, psychological reactions to the
disease; b) existing difficult social and/or psychological life
conditions with no direct relationship to RA; or c) strained
social and/or psychosocial conditions difficult to combine
with adaptation to RA. Goals for intervention by the med-
ical social worker were: a) to strengthen the patients’ cap-
acity to cope with their problems and b) to affect the
patients’ social situation positively according to Swedish
practice for psychosocial work in healthcare (Gafvels et al.
2012). An intervention goal for each patient was set ac-
cording to his/her problems or needs. The sessions lasted
for one hour, and in mean the patients had 10 sessions
each during a three months’ period.
Measurements
Social situation, i.e. family, education, employment, hous-
ing, certain life events, life style habits, social network
and support, was measured by a questionnaire from the
Epidemiological Investigation on Rheumatoid Arthritis
study (EIRA) exploring environmental and genetic risk
factors in the development of RA that started in 1997
(Bengtsson et al. 2009). Social support was measured with
questions regarding support from workmates, and from
people outside family and work. Questions about attitudes
to, knowledge about and consequences of RA, were in-
cluded in the questionnaire. Educational level was defined
as the highest completed level reached, i.e. compulsory
school, high school, or university.
The Hospital Anxiety and Depression Scale (HADS),
which was developed by Zigmond and Snaith to detect
anxiety and depression in patients with somatic condi-
tions (Zigmond and Snaith 1983), was used to measure
anxiety and depression at baseline and at 24 months.
The HADS has been evaluated in a Swedish population
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0.84, and for HADS-D 0.82. The questionnaire is self-
administered and consists of two subscales (anxiety and
depression) with 7 items, each rated on a 4-point Likert
scale from “no” to “maximum”. According to Zigmond
and Snaith, items are summed into a dimensional score
for anxiety and depression, respectively, with ≤ 7 indicat-
ing “no case”, 8–10 “possible case”, and ≥11 “probable
case”.
The 13-item Sense of Coherence (SOC) scale, developed
and modified by Antonovsky, measures attitudes and
resources for handling psychosocial stress (Antonovsky
1993). Important components measured by the scale in-
clude comprehensiveness, meaningfulness, manageability,
and resistance resources. The scale should be treated as
a single entity with no subscales, and the values may
vary between 13 and 91. The higher the SOC scores, the
better the ability to cope with stress. Cronbach’s alpha in
SOC-13 was 0.74–0.91 in performed studies (Antonovsky
1993).
Coping strategies were measured with the General
Coping Questionnaire (GCQ). This questionnaire was based
on Lazarus’ model (Lazarus and Folkman 1984), further
developed and evaluated by Persson (Persson et al. 2013),
and has previously been used in studies of patients with
diabetes (Gafvels and Wandell 2006, 2007). The instru-
ment is divided into five coping orientations dichotomized
into positive and negative opposites; i.e., self-trust/fatalism,
problem-focusing/resignation, cognitive revaluation/protest,
social trust/isolation, and minimization/intrusion. The 10
items are rated between 0 and 100, with 0 signifying the
lowest and 100 the highest possible score on the specific
scale, i.e. 100 is the best positive on the positive scales and
the worst possible on the negative ones. Cronbach’s alpha
for the different scales was 0.74–0.91 (Persson et al. 2013).
Collection of psychosocial data
Participants filled in the questionnaires, i.e. social situ-
ation (EIRA), depression and anxiety (HADS), and cop-
ing attitude and strategies (SOC and GCQ), at baseline,
i.e. within 3 months after diagnosis, and 24 months after
diagnosis. Upon inclusion, an experienced medical social
worker not involved in the study performed an interview
using a structured form (Additional file 1), described in
our earlier paper of the baseline examination of the sam-
ple (Gafvels et al. 2012).
Collection of clinical data
Data were derived from the Swedish Rheumatology Quality
Register (SRQ) (Askling et al. 2006), and are based on
assessments by a rheumatology team of the Karolinska
Hospital. The team consists of a rheumatologist, a nurse,
a medical social worker, a physiotherapist and an occupa-
tional therapist. The severity of the disease was assessedby the Disease Activity Score for 28 joints (DAS 28)
(Prevoo et al. 1995), Health Assessment Questionnaire
(HAQ) (Ekdahl et al. 1988), the patients Visual Analogue
Scale (VAS) for global perceived disease activity assessed
during the last week (scores 0–100), i.e. “How have you
been the last week, in general, given your arthritis?”, with
0 signifying “entirely good” and 100 “as bad as can be
imagined”, and joint pain (Kalyoncu et al. 2009), and fi-
nally the rheumatologist assessment score of 0–5 for
overall disease activity. DAS 28 is based on both patient
scoring of global disease impact and clinical data including
a score of tender and swollen joints, and the erythrocyte
sedimentation rate (ESR). HAQ evaluates daily activity
functions of the patients, with difficulties in 8 domains
such as dressing, arising, eating, walking, hygiene, reach-
ing, gripping, and other activities. Along with the core set
DAS 28 a rheumatologist assessed the over-all disease
activity with a 5-graded Likert scale (1: no disease activity;
2: low disease activity; 3: moderate disease activity; 4: high
disease activity; and 5: maximal disease activity). Medical
treatment was initiated at the time of diagnosis. The stud-
ied patients’ pharmacological treatment was not known,
but since all these patients belonged to an early arthritis
clinic we can assume that the pharmacological treatment
was according to the guidelines for early rheumatoid arth-
ritis. The SRQ Register report that the initial treatment for
early rheumatoid arthritis in Stockholm the years 2001–
2004 was Methotrexate 54–70%, Sulphasalazine 21–11%,
biologics 3,5–4%, combinations 1,5–5%, others 4,5–2%.
16–7% were not treated initially (Askling et al. 2006).
There is no report on how many patients were treated
with low-dose corticosteroids in the Register but this was
done quite often, as well as treatment with intra-articular
corticosteroid injections.
Statistical analysis
Results were analyzed in crosstabs and multivariate ana-
lyses. First, we compared differences within groups over
time and between groups. Statistical methods used to
calculate significant differences were Chi-square, Fisher’s
exact test, Wilcoxon’s paired test, and Mann Whitney’s
test. Secondly, we present results from the HADS, SOC,
and GCQ scales as median values with interquartile
ranges because of significant skewness. The level of
statistical significance was set at p <0.01, due to mul-
tiple comparisons, but in change over time at p <0.05.
Thirdly, we performed age- and sex-adjusted logistic re-
gression models for each factor of interest, using the
effects of the disease experienced at 24 months, dichot-
omized as great versus not, as the dependent variable. As
independent factors we tested the social background
variables, emotional status, coping strategies, disease-
related data and self-reported reaction data at baseline.
Fourthly, we performed a multivariate analysis, again
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the dependent variable, with adjustment for age and sex
and including factors with p < 0.1. We tested model speci-
fication and Goodness-of-fit by Hosmer-Lemeshow’s test.
Ethical considerations
This study was approved by the Research Ethics Com-
mittee at Karolinska Institutet (No. 00–065). Informa-
tion to the participants was given by the nurse at the
early arthritis clinic at the Department of Rheumatology,
and participants gave their oral consent before respond-
ing to the questionnaires. ClinicalTrials.gov. identifier:
NCT01066130.Table 1 Self-reported demographic and social background of






Men 7 (17%) –
Women 34 (83%) –
Mean age, years (SD) 44.4 (11.2)
Born in Sweden 35 (85%) –
Marital status: 0
Married 13 (32%) 12 (29%)
Unmarried 15 (37%) 15 (37%)
Divorced/widowed 13 (32%) 14 (34%)
Living with partner 21 (51%) 18 (44%) 0
Living alone 17 (42%) 15 (37%)
Living with children 23/39 (59%) 19 (48%) 0
Educational level:
Compulsory school 12 (32%) –
High school 15 (41%) –
University 10 (27%) –
Employed 22 (54%) 17 (41%) 0
On early pension/long-term sick-leave 14 (34%) 21 (51%)
Other 5 (12%) 3 (7%)
Difficult financial situation 10 (24%) 14 (34%) 0
Financial problems* 10 (24%) 18 (44%) 0.0
Own their residence 20 (74%) 21 (51%) 0
Social support:
From workmates 19/33 (58%) 17/33 (52%) 0
Outside family and work 35 (85%) 34 (83%) 0
Affinity with workmates 18/33 (55%) 20/34 (59%) 0
Good relationship with≥ 3 workmates 10/33 (30%) 16/33 (48%) 0
Figures at baseline and after 24 months.
(Results given as numbers and percentages unless otherwise is stated).
*Have had difficulties paying bills during the last 12 months.
PSP = Patients with psychosocial problems.
NPSP = Patients with no psychosocial problems.Results
Self-reported demographic and social background data
are shown in Table 1. Most patients in each group were
women, without significant difference in distribution be-
tween the groups, 83% in the PSP group vs. 70% in the
NPSP group. The differences in social situation between
PSP and NPSP patients were unchanged from baseline to
follow-up, i.e. the PSP patients were younger, more often
unmarried, divorced, or widowed, more often reported a
strained financial situation, and more often were on long-
term sick-leave or early retirement pension. PSP patients
also reported less affinity with workmates both at baseline














– 16 (30%) – – 0.16 –
– 38 (70%) – – –
50.4 (10.5) 0.0060
– 47/52 (90%) – – 0.46 –
.96 0.91 <0.001 <0.001
39 (72%) 41 (76%)
8 (15%) 7 (13%)
7 (13%) 6 (11%)
.29 42 (78%) 42 (78%) 1.00 0.018 0.003
9 (17%) 9 (17%)
.26 21 (39%) 19/53 (36%) 0.75 0.056 0.30
0.31 –
– 16 (31%) – – –
– 14 (28%) – – –
– 21 (41%) – – –
.31 42 (78%) 39 (72%) 0.080 0.004 0.005
4 (7%) 11 (20%)
8 (15%) 4 (7%)
.94 0 (0%) 2 (4%) 0.50 <0.001 <0.001
62 2 (4%) 2 (4%) 1.00 0.004 <0.001
.83 36 (67%) 35 (65%) 0.84 0.079 0.18
.62 30/46 (65%) 36/48 (75%) 0.30 0.48 0.029
.76 46/52 (89%) 51/54 (94%) 0.32 0.66 0.095
.72 37/46 (80%) 43/48 (90%) 0.21 0.014 0.001
.13 23/47 (49%) 32/48 (67%) 0.080 0.096 0.10
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problems in the PSP group, 15 (37%) had problems solely
as a consequence of their RA, 9 (22%) had problems in
their life situation in general not connected to RA, and for
the remaining 17 (42%) problems were related to RA in
combination with an already strained life situation.
Table 2 shows data on the participants’ psychological
state as regards anxiety, depression, sense of coherence,
and coping strategies. The PSP patients had higher anx-
iety and depression scores and lower SOC scores than
had NPSP patients on both occasions. With respect to
coping strategies, PSP patients showed significantly
higher, i.e. worse, scores on protest, isolation and intru-
sion, and lower scores, i.e. worse, on minimization, on
both occasions. Differences found only at 24 months
concerned: self-trust, with a lower score (i.e. worse); fa-
talism, with a higher score (i.e. worse); and social trust,
with a higher score (i.e. better) in the PSP group. Con-
cerning changes over time, the PSP group had a de-
creased score only for intrusion (i.e. improved). For the
NPSP group there were several significant changes over
time: increased scores for self-trust and cognitive re-
valuation (i.e. improved); decreased scores for protest,Table 2 Emotional status and coping strategies of patients 20









(n = 41) p-values* (n = 54)
HADS scores
Anxiety 9.0 (5.5–12.0) 8.0 (4.5–12.0) 0.24 4.0 (2.0–7.3
Depression 6.0 (4.0–8.5) 5.0 (2.0–9.0) 0.42 3.0 (1.0–5.0
SOC scores 62 (56–70) 60 (50–70) 0.040 73 (66–81
Low SOC 12 (29%) 23 (56%) 0.039 11 (20%)
Moderate SOC 18 (44%) 13 (32%) 27 (50%)
High SOC 11 (27%) 5 (12%) 16 (30%)
Coping strategies
(GCQ)
Self-trust 80 (60–85) 75 (60–85) 0.24 82.5 (70–9
Fatalism 30 (20–35) 30 (20–40) 0.28 20 (10–35
Problem focusing 85 (75–95) 85 (60–90) 0.15 88 (80–95
Resignation 20 (10–25) 17.5 (1.3–23.8) 0.28 10 (0–20)
Cognitive revaluation 40 (25–60) 45 (30–70) 0.13 35 (25–50
Protest 40 (25–65) 40 (20–65) 0.95 20 (6–34)
Social trust 87 (75–100) 87 (67–98) 0.19 90 (78–100
Isolation 20 (12–40) 28 (16–36) 0.44 8 (0–16)
Minimization 72 (56–80) 68 (56–80) 0.68 84 (65–92
Intrusion 40 (25–56) 30 (20–50) 0.026 20 (10–39
Results presented as medians (interquartile range).
*P values analyzed within groups by Wilcoxon’s paired test, and between groups M
PSP = Patients with psychosocial problems.
NPSP = Patients with no psychosocial problems.and intrusion (i.e. improved); and decreased scores
for problem-focusing and social trust (i.e. worse). By
means of comparing the groups’ Δ values over time,
the only significant difference found was in self-trust,
which was higher, i.e. better, in the NPSP group than
the PSP group.
Table 3 shows that disease-related activity, bothself-
reported and physician-assessed, decreased significantly
over time in both groups. Scores for self-reported global
perceived disease activity and pain were higher in the
PSP group both at baseline and at follow-up. When
comparing PSP patients (n = 24) who had achieved their
psychosocial treatment goals after 24 months to those
who had not (n = 16), significantly lower scores for glo-
bal perceived disease activity at follow-up were found,
24.5 vs 48.0 (p = 0.001). As regards global perceived dis-
ease activity at baseline, there was no significant difference
according to the chosen p-level of 0.01 (median 58.0 vs
68.5 (p = 0.014). When PSP patients’ problems were strati-
fied as a) problems caused by the disease (n = 15), b) diffi-
cult social and/or psychological life conditions not caused
by RA (n = 9) or c) a combination of both (n = 17), their











p-values* p-values* p-values* p-values*
) 3.0 (1.0–5.0) 0.008 0.57 <0.001 <0.001
) 2.0 (1.0–4.3) 0.033 0.69 <0.001 <0.001
) 71 (66–80) 0.56 0.90 <0.001 <0.001
8 (15%) 0.51 0.60 <0.001
24 (45%)
21 (40%)
0) 85 (75–100) 0.012 0.012 0.23 <0.001
) 20 (5–34) 0.66 0.27 0.064 0.0054
) 80 (68–95) 0.008 0.50 0.61 0.87
15 (0–25) 0.14 0.08 0.024 0.93
) 55 (40–79) 0.004 0.54 0.69 0.30
12.5 (5–24) 0.008 0.29 <0.001 <0.001
) 80 (60–87) <0.001 0.17 0.77 <0.001
12 (4–16) 0.97 0.53 <0.001 <0.001
) 80 (72–88) 0.83 0.76 0.0053 0.0010
) 15 (5–24) 0.001 0.55 <0.001 <0.001
ann–Whitney test.
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p = 0.008) and c) (67 vs 42, p = 0.021), but not in b) (55.0
vs 45.5, p = 0.58).
Table 4 shows self-reported reactions to RA. Experi-
ences at 24 months appeared worse than expectations at
baseline for both groups. In regard to social and eco-
nomic consequences of RA, significantly more PSP pa-
tients reported an effect on all areas of interest with
exception of work. More PSP patients than NPSP patients
reported that they had given up leisure activities because
of their symptoms both at baseline and 24 months.
Table 5 shows the results of age-adjusted logistic regres-
sion models on background factors at baseline, predicting
experience of strong influence of RA at 24 months. Firstly,
age- and sex-adjusted models for each factor are shown,
and secondly a multivariate model, with adjustment for
age and sex, and otherwise factors with p-value < 0.1 in-
cluded. The only statistically significant factor was higher
scores on HADS depression scale (p = 0.037). The model
was tested for goodness-of-fit by Hosmer-Lemeshow’s
test, p = 0.92.
Discussion
The main aim of this study was to investigate predictive
factors for negative experienced effects of RA by the pa-
tients. We found that having higher scores on HADS de-
pression was the only statistically significant predictor of
perceived negative effects 24 months after diagnosis, be-
ing a consistent finding after adjustment and seemingly
robust. Besides, differences between PSP patients and
NPSP patients present at baseline were lasting over the
two-year period.Table 3 Clinical data on patients 20–65 years who participate










(n = 41) p-values* (n = 54)
Other important
disease
16 (39%) 24 (45%)
DAS-28 5.67 (4.72–6.36) 3.30 (2.45–4.34) <0.001 5.09 (49–5.66





64 (42–77) 37 (20–67) <0.001 44 (24–67)
Patient-reported
pain




3.0 (3.0–4.0) 2.0 (1.3–2.0) <0.001 3.0 (3.0–3.0)
Results presented as medians (interquartile range). Comparing data at diagnosis (or
*P values analyzed within groups by Wilcoxon’s paired test, and between groups M
PSP = Patients with psychosocial problems.
NPSP = Patients with no psychosocial problems.The consisting differences between the PSP and NPSP
groups over time, as well as the impact of the depression
score on experienced impact of RA, are in line with find-
ings by Evers et al., who found that stress-vulnerability
factors seem to operate in the long run (Evers et al.
2003). Our results also was in line with findings from a
recent study finding two subgroups of RA patients, with
subjects characterized as belonging to one type (29%)
being more prone to greater emotional expression and
also to more time with depression (Tillmann et al. 2013).
Another possibility could be that this psychosocial vulner-
ability could be a risk factor for developing RA, which not
has been reported earlier, even if low socio-economic
status has (Scott et al. 2011). No significant changes in
social background variables over time between the two
groups were found. However, the negative impact of the
disease experienced after two years was stronger in
both groups than expected at baseline. By contrast, both
groups showed a significant improvement in clinical status
over time, most likely an effect of successful medical RA
treatment.
The psychological status regarding anxiety and depres-
sion was worse in PSP patients on both occasions,
whereas the anxiety scores decreased significantly over
time only in the NPSP group. We do not know to what
extent the RA diagnosis affected the psychological status.
The NPSP patients seemed to have a more successful way
of dealing with the initial crisis reaction, supported by the
decreased anxiety scores, but also the increased use of the
coping strategy “cognitive revaluation”, and decreased use
of “protest” and “intrusion”. However, the PSP patients













p-values* p-values* p-values* p-values*
0.54
) 3.08 (2.18–3.86) <0.001 0.39 0.023 0.26
) 0.25 (0.00–0.63) <0.001 0.11 0.15 <0.001
21 (7–49) <0.001 0.62 0.0024 0.019
18 (5–50) <0.001 0.89 0.028 0.011
2.0 (1.0–2.0) <0.001 0.59 0.59 0.43
at 6 months) with at 24 months (or at 18 months).
ann–Whitney test.
Table 4 Self-reported reaction to the diagnosis in patients 20–65 years who participated in this study on adaptation to

















(n = 41) p-values* (n = 54) p-values* p-values* p-values*
Sufficient knowledge about RA 31 (78%) 39 (75%) 0.78
Insufficient knowledge 9 (23%) 13 (25%)
Impact of the disease: <0.001 0.002 0.014 <0.001
Not at all or little 6 (15%) 0 (0%) 12 (23%) 5 (9%)
Moderately 23 (58%) 12 (29%) 38 (72%) 32 (60%)
A lot 11 (28%) 29 (71%) 3 (6%) 16 (30%)
Influenced areas:
Relationship to partner – 16/39 (41%) – – 7/43 (16%) – – 0.013
Sexual life – 15/39 (39%) – – 8/44 (18%) – – 0.039
Family life – 21/39 (54%) – – 10/42 (24%) – – 0.005
Social life – 24/38 (63%) – – 13/42 (31%) – – 0.004
Work – 27/40 (68%) – – 22/42 (52%) – – 0.16
Economy – 27/40 (68%) – – 12/43 (28%) – – <0.001
Leisure time activities – 35/39 (90%) – – 25/43 (58%) – – 0.002
Forgo leisure-time activities because of symptoms 32 (78%) 29 (71%) 0.45 29 (54%) 18 (33%) 0.033 0.014 <0.001
Smoking habits: 0.90 0.10 0.68 0.11
Non-smokers 23 (56%) 25 (61%) 33 (65%) 42 (78%)
Occasional smokers 5 (12%) 4 (10%) 6 (12%) 1 (2%)
Daily-smokers 13 (32%) 12 (29%) 12 (24%) 11 (20%)
Physical activity 0.76 0.89 0.89 0.96
Weekly 35 (85%) 34 (83%) 43 (84%) 45 (83%)
Less than weekly 6 (15%) 7 (17%) 8 (16%) 9 (17%)
Impact of the disease at baseline denotes expected impact, while at 24 months experienced impact.
*P values analyzed by Chi-square analysis, PSP = Patients with psychosocial problems, NPSP = Patients with no psychosocial problems.
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http://www.springerplus.com/content/3/1/118at diagnosis as also found in other studies (Hyphantis
et al. 2006). The PSP group also seemed to have less suc-
cessful coping strategies, with more often use of “protest”,
“isolation” and “intrusion”, and less of “minimization”.
Despite the improvement in clinical status, the scores
for anxiety and depression did not decrease in the PSP
group, which support the conclusion that what is im-
portant from the patient’s point of view is not the RA
status as such but the psychological vulnerability, coping
pattern and the social situation, which is at least partly
in line with earlier findings (Curtis et al. 2005; Groarke
et al. 2004). It appeared to be a discrepancy between the
objectively measured disease activity on one hand, and
the self-reported global sickness score, mood, and cop-
ing strategies on the other hand. As the presence of anx-
iety and depression may disturb the adaptation to RA,
and possibly also the treatment at least as regards adher-
ence, this underscores the need of finding markers of
such problems early in the course of the disease (Isik
et al. 2007).Overall, PSP patients scored higher on negative coping
strategies than did NPSP patients, as measured by GCQ.
This is in line with findings of earlier studies that showed
an association between these strategies and psycho-
social and socio-economic problems (Gafvels et al. 2012;
Rane et al. 2011; Gafvels and Wandell 2006, 2007). Fur-
thermore, studies on coping using other instruments have
shown that passive coping, i.e. “efforts to avoid or deny
the stressor” (Compas et al. 2012), which could also be
regarded as a negative coping strategy, was associated
with increased pain (Covic et al. 2000), while active
coping, i.e. “efforts to act on the source of stress or
one’s emotions” (Compas et al. 2012), could counteract
the negative effect of perceived stress (Treharne et al.
2007). Furthermore, the adaptive strategies acceptance
and problem solving are found to predict lower levels of
psychopathology (Aldao and Nolen-Hoeksema 2012).
Low social support, especially support from workmates,
which was reported more often by PSP than NPSP pa-
tients, has previously been shown to be associated with
Table 5 Results of logistic regression, with strong impact of the disease at 24 months as outcome, in age-and
sex-adjusted models for each tested variable, and multivariate model with adjustment for age, sex and educational
level, but otherwise with factors with factors showing p-value < 0.1 included
Factor Sex and age-adjusted models Multivariate model
OR (95% CI) OR (95% CI)
Age 0.99 (0.96–1.03) 1.01 (0.95–1.07)
Sex (women vs men) 1.01 (0.39–2.60) 0.61 (0.16–2.22)
Educational level:
Compulsory school 1 (ref) 1 (ref)
High school 0.46 (0.14–1.51) 0.30 (0.07–1.31)
University 0.27 (0.08–0.85) 0.29 (0.07–1.21)
Employed 1 (ref)
On early pension/long-term sick-leave 5.05 (1.49–17.15)
Other 0.88 (0.26–2.99)
Difficult financial situation 12.35 (1.47–103.72)
Financial problems* 6.88 (1.39–34.08)
PSP group 1 (ref) 1 (ref)
NPSP group 0.38 (0.23–0.63) 0.57 (0.31–1.05)
HAQ 2.53 (1.11–5.73)
Patient-reported global perceived disease activity score 1.03 (1.01–1.04)
Patient-reported pain 1.03 (1.01–1.05)
HADS anxiety 1.28 (1.13–1.45)
HADS depression 1.50 (1.24–1.80) 1.45 (1.18–1.77)




Problem focusing 1.00 (0.97–1.03)
Resignation 1.02 (0.99–1.05)
Cognitive revaluation 0.99 (0.97–1.01)
Protest 1.03 (1.01–1.05)




Results presented as odds ratios (ORs), with 95% confidence intervals (95% CI).
*Have had difficulties paying bills during the last 12 months.
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2003). This is in line with our finding with higher scores
on self-reported sickness variables in PSP patients, in
contrast to the lack of difference between the two
groups in the disease activity score recorded by the
rheumatologist.
Moreover, the patients who achieved their treatment
goals of the psychosocial intervention experienced milder
effects of the disease. RA patients with psychosocial prob-
lems due to the disease found it easier to achieve treat-
ment goals than RA patients with problems due to othercauses than the RA itself. This finding is important for
tailoring psychosocial work to individual RA patient
needs. Without the intervention the PSP patients could
probably have been even worse off, but it is not possible
to grade the magnitude of the effect due to lack of a
control group not receiving this kind of intervention.
An earlier meta-analysis found positive effects of psy-
chosocial interventions in RA and osteoarthritis patients,
with reductions in pain, anxiety, depression and psycho-
logical disability, and an improvement in active coping
(Dixon et al. 2007).
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The strength of the study is that it explored psychosocial
problems in a sample of patients with RA, derived dir-
ectly from everyday clinical practice, and the fact that
we have used several well validated questionnaires to
verify them. Besides, the differences between the two
groups showed highly statistically significant results, and
the final multivariate statistical model showed excellent
goodness-of-fit.
One major limitation with this study is the small num-
ber of participants, which made it difficult to detect
small differences between PSP and NPSP patients, espe-
cially over time. Thus, smaller but clinically relevant dif-
ferences may not have adequately surfaced in the analyses.
With regard to the size of the study groups, it was not
possible, for ethical reasons, to have a sufficiently large
group of RA patients with psychosocial problems not re-
ceiving any intervention as controls, and thus we cannot
value the effect of the social worker’s intervention. Divid-
ing the patients into two groups based on the presence
or absence of psychosocial problems was done according
to accepted clinical assessment criteria, i.e. whether
the patients reported problems that required psychosocial
intervention or not. However, the validity of this clin-
ical classification was supported by the results of the
self-reported questionnaires (HADS and SOC). The
withdrawal rate was 19%, but there were no signifi-
cant differences regarding age and sex between partic-
ipants and non-participants, so the results could not
be expected to be affected by this.
DAS28 could be problematic as a measurement of
medical severity of RA, as part of the assessment is pa-
tient scoring of global disease impact on a VAS scale,
and could be strongly affected by the patients’ psycho-
social status. The use of the overall disease activity score
assessed by rheumatologist could be questioned, but this
score is a complement to DAS28 and other patient per-
ceived disease activity, and is also reported to the SRQ
Register. Besides, CRP values were not available. Further-
more, we did not have access to the specific treatment of
the patients, but assume that this was in accordance with
the treatment guidelines.
Implications
Our findings, i.e. that having psychosocial problems
already at diagnosis and higher scores on HADS depres-
sion scale, predicted a stronger negative impact of the
disease at the 24-month follow-up, show the importance
of recognizing emotional and social problems early in
the course of RA (Hyphantis et al. 2006; Benka et al.
2013). Psychosocial problems increase the burden of the
disease, including higher symptoms of anxiety and depres-
sion, and could affect the adherence to the medical treat-
ment. Actually, without the psychosocial intervention inthe PSP group the differences and impact of the disease
would probably have been even more pronounced. This is
an important knowledge for the rheumatologist, and a
medical social worker should be a natural member of
every RA team. The patients with psychosocial problems
were identified by a semi-structured interview, and there-
fore it is important that medical social workers with
knowledge about RA care should be available to support
patients early in the course of the disease, rather than to
use a questionnaire. Goals for further research could be to
identify markers for a worse outcome, and to tailor spe-
cific actions. Psychosocial treatment goals seem to be easi-
est to achieve among RA patients with disease-related
problems, and could preferably be treated by the medical
social workers linked to the rheumatology department.
Patients with other types of problems seem to need more
extended support outside the hospital clinic. Besides, one
could speculate in if the psychosocial vulnerability could
be a risk factor for developing RA in genetically suscep-
tible individuals, but this has to be analyzed in future
studies.
Additional file
Additional file 1: Interview form for medical social worker.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CG and MH planned and performed the study, BN provided medical data,
PW performed the statistical analyses in discussion with CG, CG and PW
drafted the manuscript, MH and BN read and commented on the
manuscript, and all authors read and approved the final manuscript.
Acknowledgements
This study was supported by grants from the Swedish Rheumatism
Association and the Norrbacka-Eugenia Foundation. A special thank to
Professor Lars Klareskog at the Department of Rheumatology at Karolinska
University Hospital, and Professor Lars Alfredsson at the Institute of
Environmental Medicine Karolinska Institutet, for access to important data
from the EIRA study. A special thank also to Scientific Editor Kimberly Kane at
the Center for Family and Community Medicine and PhD Maria Flink at the
Department of Social Work, Karolinska University Hospital, for valuable
assistance.
Author details
1Department of Social Work, Karolinska University Hospital, Solna 171 76,
Stockholm, Sweden. 2Centre for Family Medicine, Karolinska Institutet, Alfred
Nobels allé 12, Huddinge 141 83, Sweden. 3Department of Rheumatology,
Karolinska University Hospital, Solna 171 76, Stockholm, Sweden.
Received: 13 February 2014 Accepted: 27 February 2014
Published: 28 February 2014
References
Albers JM, Kuper HH, van Riel PL, Prevoo ML, Hof MA v 't, Van Gestel AM,
Severens JL (1999) Socio-economic consequences of rheumatoid arthritis in
the first years of the disease. Rheumatology 38(5):423–430
Aldao A, Nolen-Hoeksema S (2012) The influence of context on the implementation
of adaptive emotion regulation strategies. Behav Res Ther 50(7–8):493–501
Antonovsky A (1993) The structure and properties of the sense of coherence
scale. Soc Sci Med 36(6):725–733
Gåfvels et al. SpringerPlus 2014, 3:118 Page 10 of 10
http://www.springerplus.com/content/3/1/118Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N,
Lindblad S, Klareskog L (2006) Swedish registers to examine drug safety and
clinical issues in RA. Ann Rheum Dis 65(6):707–712
Astin JA, Beckner W, Soeken K, Hochberg MC, Berman B (2002) Psychological
interventions for rheumatoid arthritis: a meta-analysis of randomized
controlled trials. Arthritis Rheum 47(3):291–302
Bengtsson C, Theorell T, Klareskog L, Alfredsson L (2009) Psychosocial stress at
work and the risk of developing rheumatoid arthritis: results from the
Swedish EIRA study. Psychother Psychosom 78(3):193–194
Benka J, Nagyova I, Rosenberger J, Calfova A, Macejova Z, Lazurova I, van Dijk JP,
Groothoff JW (2013) Social support as a moderator of functional disability’s
effect on depressive feelings in early rheumatoid arthritis: a four-year
prospective study. Rehabil Psychol, [Epub ahead of print], PMID: 24320944
Compas BE, Jaser SS, Dunn MJ, Rodriguez EM (2012) Coping with chronic illness
in childhood and adolescence. Annu Rev Clin Psychol 8:455–480
Covic T, Adamson B, Hough M (2000) The impact of passive coping on
rheumatoid arthritis pain. Rheumatology (Oxford) 39(9):1027–1030
Curtis R, Groarke A, Coughlan R, Gsel A (2005) Psychological stress as a predictor
of psychological adjustment and health status in patients with rheumatoid
arthritis. Patient Educ Couns 59(2):192–198
Dixon KE, Keefe FJ, Scipio CD, Perri LM, Abernethy AP (2007) Psychological
interventions for arthritis pain management in adults: a meta-analysis.
Health Psychol 26(3):241–250
Ekdahl C, Eberhardt K, Andersson SI, Svensson B (1988) Assessing disability in
patients with rheumatoid arthritis. Use of a Swedish version of the Stanford
Health Assessment questionnaire. Scand J Rheumatol 17(4):263–271
Evers AW, Kraaimaat FW, Geenen R, Jacobs JW, Bijlsma JW (2003) Stress-
vulnerability factors as long-term predictors of disease activity in early
rheumatoid arthritis. J Psychosom Res 55(4):293–302
Gafvels C, Wandell PE (2006) Coping strategies in men and women with
type 2 diabetes in Swedish primary care. Diabetes Res Clin Pract
71(3):280–289
Gafvels C, Wandell PE (2007) Coping strategies in immigrant men and women
with type 2 diabetes. Diabetes Res Clin Pract 76(2):269–278
Gafvels C, Hagerstrom M, Nordmark B, Wandell PE (2012) Psychosocial problems
among newly diagnosed rheumatoid arthritis patients. Clin Rheumatol
31(3):521–529
Geuskens GA, Burdorf A, Hazes JM (2007) Consequences of rheumatoid
arthritis for performance of social roles–a literature review. J Rheumatol
34(6):1248–1260
Groarke A, Curtis R, Coughlan R, Gsel A (2004) The role of perceived and actual
disease status in adjustment to rheumatoid arthritis. Rheumatology (Oxford)
43(9):1142–1149
Hyphantis TN, Bai M, Siafaka V, Georgiadis AN, Voulgari PV, Mavreas V, Drosos AA
(2006) Psychological distress and personality traits in early rheumatoid
arthritis: a preliminary survey. Rheumatol Int 26(9):828–836
Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with
rheumatoid arthritis. Clin Rheumatol 26(6):872–878
Kalyoncu U, Dougados M, Daures JP, Gossec L (2009) Reporting of patient-reported
outcomes in recent trials in rheumatoid arthritis: a systematic literature review.
Ann Rheum Dis 68(2):183–190
Lazarus RS, Folkman S (1984) Stress, appraisal and coping. Springer Publishing
Company, New York
Levin RW, Park J, Ostrov B, Reginato A, Baker DG, Bomalaski JS, Borofsky M,
Gardiner M, Leventhal L, Louthrenoo W, von Feldt J, Kolasinski S,
Schumacher HR Jr (1996) Clinical assessment of the 1987 American College
of Rheumatology criteria for rheumatoid arthritis. Scand J Rheumatol
25(5):277–281
Lisspers J, Nygren A, Soderman E (1997) Hospital Anxiety and Depression Scale
(HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand
96(4):281–286
Morris A, Yelin EH, Wong B, Katz PP (2008) Patterns of psychosocial risk and long-term
outcomes in rheumatoid arthritis. Psychol Health Med 13(5):529–544
Persson LO, Berglund K, Sahlberg D (1999) Psychological factors in chronic
rheumatic diseases–a review. The case of rheumatoid arthritis, current
research and some problems. Scand J Rheumatol 28(3):137–144
Persson LO, Erichsen M, Wandell P, Gafvels C (2013) Psychometric evaluation of a
coping questionnaire in two independent samples of people with diabetes.
Stress Health 29(4):286–296
Prevoo ML, van’tHof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel
PL (1995) Modified disease activity scores that include twenty-eight-jointcounts. Development and validation in a prospective longitudinal study of
patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48
Rane K, Wajngot A, Wandell PE, Gafvels C (2011) Psychosocial problems in
patients with newly diagnosed diabetes: number and characteristics.
Diabetes Res Clin Pract 93(3):371–378
Schnyder U, Buchi S, Morgeli H, Sensky T, Klaghofer R (1999) Sense of coherence
- a mediator between disability and handicap? Psychother Psychosom
68(2):102–110
Scott IC, Steer S, Lewis CM, Cope AP (2011) Precipitating and perpetuating
factors of rheumatoid arthritis immunopathology: linking the triad of genetic
predisposition, environmental risk factors and autoimmunity to disease
pathogenesis. Best Pract Res Clin Rheumatol 25(4):447–468
Simonsson M, Bergman S, Jacobsson LT, Petersson IF, Svensson B (1999) The
prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol
28(6):340–343
Soderlin MK, Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M (2002) Annual
incidence of inflammatory joint diseases in a population based study in
southern Sweden. Ann Rheum Dis 61(10):911–915
Sokka T (2003) Work disability in early rheumatoid arthritis. Clin Exp Rheumatol
21(5 Suppl 31):S71–S74
Strating MM, Suurmeijer TP, van Schuur WH (2006) Disability, social support, and
distress in rheumatoid arthritis: results from a thirteen-year prospective study.
Arthritis Rheum 55(5):736–744
Tillmann T, Krishnadas R, Cavanagh J, Petrides K (2013) Possible rheumatoid
arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay
and emotional expression: an exploratory case–control study. Arthritis Res
Ther 15(2):R45
Treharne GJ, Kitas GD, Lyons AC, Booth DA (2005) Well-being in rheumatoid
arthritis: the effects of disease duration and psychosocial factors. J Health
Psychol 10(3):457–474
Treharne GJ, Lyons AC, Booth DA, Kitas GD (2007) Psychological well-being across
1 year with rheumatoid arthritis: coping resources as buffers of perceived
stress. Br J Health Psychol 12(Pt 3):323–345
Vriezekolk JE, van Lankveld WG, Geenen R, van den Ende CH (2011) Longitudinal
association between coping and psychological distress in rheumatoid
arthritis: a systematic review. Ann Rheum Dis 70(7):1243–1250
Walker JG, Jackson HJ, Littlejohn GO (2004) Models of adjustment to chronic
illness: using the example of rheumatoid arthritis. Clin Psychol Rev
24(4):461–488
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta
Psychiatr Scand 67(6):361–370
Zyrianova Y, Kelly BD, Gallagher C, McCarthy C, Molloy MG, Sheehan J, Dinan TG
(2006) Depression and anxiety in rheumatoid arthritis: the role of perceived
social support. Ir J Med Sci 175(2):32–36
doi:10.1186/2193-1801-3-118
Cite this article as: Gåfvels et al.: What predicts negative effects of
rheumatoid arthritis? A follow-up two years after diagnosis. SpringerPlus
2014 3:118.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
